Download PDF
Klinische Neurophysiologie 2001; 32(4): 225-231
DOI: 10.1055/s-2001-18955
Originalia
© Georg Thieme Verlag Stuttgart · New York

Botulinumtoxin Typ A in der Schmerztherapie - theoretische Grundlagen und praktische Anwendung

Botulinum Toxin Type A for the Treatment of Pain - A Theoretical and Practical ApproachJ.  D.  Rollnik1
  • 1Neurologische Klinik mit Klinischer Neurophysiologie, Medizinische Hochschule Hannover
Further Information

Publication History

Publication Date:
11 December 2001 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Botulinumtoxin Typ A wird seit vielen Jahren in der Schmerztherapie eingesetzt. Neben einem analgetischen Effekt bei Dystonien sowie der Spastik wurde es experimentell bei myofaszialen Schmerzsyndromen, beim Kopfschmerz vom Spannungstyp, Migräne, Clusterkopfschmerz und bei Lumbago verwendet. Der vorliegende Artikel gibt einen Überblick über die vorliegende Literatur und stellt auch die zugrunde liegenden pathophysiologischen Überlegungen vor.

Abstract

Botulinum A toxin has been used for the treatment of pain for many years. Besides pain relief in dystonia and spasticity, it has been tried in myofascial pain syndromes, tension-type headaches, migraine, cluster headache, and back pain. This article gives a review of the existing literature and refers to pathophysiological mechanisms.

Key words

Botulinum A toxin - Pain - Treatment - Headache - Myofascial pain

Literatur

  • 1 Tsui J K, Eisen A, Mak E, Carruthers J, Scott A, Calne D B. A pilot study on the use of botulinum toxin in spasmodic torticollis.  Can J Neurol Sci. 1985;  12 314-316
    CrossrefPubMedGoogle Scholar
  • 2 Scott A B, Kennedy R A, Stubbs H A. Botulinum toxin injection as treatment for blepharospasm.  Arch Ophthalmol. 1985;  103 347-350
    CrossrefPubMedGoogle Scholar
  • 3 Rivest J, Lees A J, Marsden C D. Writer's cramp: treatment with botulinum toxin injections.  Mov Disord. 1991;  6 55-49
    CrossrefPubMedGoogle Scholar
  • 4 Meleca R J, Hogikyan N D, Bastian R W. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.  Otolaryngol Head Neck Surg. 1997;  117 487-492
    PubMedGoogle Scholar
  • 5 Brin M F, Fahn S, Moskowitz C. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.  Mov Disord. 1987;  2 237-254
    CrossrefPubMedGoogle Scholar
  • 6 Snow B J, Tsui J KC, Bhatt M H, Varelas M, Hashimoto S A, Calne D B. Treatment of spasticity with botulinum toxin: a double blind study.  Neurology. 1990;  28 512-515
    CrossrefPubMedGoogle Scholar
  • 7 Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik H H. Local botulinum toxin in the treatment of spastic drop foot.  J Neurol. 1992;  239 375-378
    PubMedGoogle Scholar
  • 8 Jankovic J, Schwartz K. Botulinum toxin treatment of tremors.  Neurology. 1991;  41 1185-1188
    CrossrefPubMedGoogle Scholar
  • 9 Davis D, Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A.  Mov Disord. 1993;  8 371-373
    CrossrefPubMedGoogle Scholar
  • 10 Polo K B, Jabbari B. Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin.  Mov Disord. 1994;  9 233-235
    CrossrefPubMedGoogle Scholar
  • 11 Cheshire W P, Abashian S W, Mann J D. Botulinum toxin in the treatment of myofascial pain syndrome.  Pain. 1994;  59 65-69
    CrossrefPubMedGoogle Scholar
  • 12 Wheeler A H, Goolkasian P, Gretz S S. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.  Spine. 1998;  23 1662-1666
    CrossrefPubMedGoogle Scholar
  • 13 Jost W H, Schimrigk K. Therapy of anal fissure using botulin toxin.  Dis Colon Rectum. 1994;  37 1321-1324
    CrossrefPubMedGoogle Scholar
  • 14 Grazko M A, Polo K B, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity.  Neurology. 1995;  45 712-717
    PubMedGoogle Scholar
  • 15 Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G. „Off” painful dystonia in Parkinson's disease treated with botulinum toxin.  Mov Disord. 1995;  10 333-336
    CrossrefPubMedGoogle Scholar
  • 16 Bushara K O, Park D M, Jones J C, Schutta H S. Botulinum toxin - a possible new treatment for axillary hyperhidrosis.  Clin Exp Dermatol. 1996;  21 276-278
    PubMedGoogle Scholar
  • 17 Garcia A, Fulton J E. Cosmetic denervation of the muscles of facial expression with botulinum toxin A dose-response study.  Dermatol Surg. 1996;  22 39-43
    CrossrefPubMedGoogle Scholar
  • 18 Fishman V M, Parkman H P, Schiano T D, Hills C, Dabezies M A, Cohen S, Fisher R S, Miller L S. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.  Am J Gastroenterol. 1996;  91 1724-1730
    PubMedGoogle Scholar
  • 19 Bjerkhoel A, Trobbe O. Frey's syndrome: treatment with botulinum toxin.  J Laryngol Otol. 1997;  111 839-844
    PubMedGoogle Scholar
  • 20 Relja M. Treatment of tension-type headache by local injection of botulinum toxin.  Eur J Neurol. 1997;  4, Suppl 2 S71-S73
    PubMedGoogle Scholar
  • 21 Schulte-Mattler W J, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study.  Eur J Med Res. 1999;  4 183-186
    PubMedGoogle Scholar
  • 22 Rollnik J D, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study.  Headache. 2000;  40 300-305
    CrossrefPubMedGoogle Scholar
  • 23 Freund B J, Schwartz M. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases.  J Rheumatol. 1999;  26 756-758
    PubMedGoogle Scholar
  • 24 Rollnik J D, Hierner R, Schubert M, Shen Z L, Tröger M, Johannes S, Wohlfarth K, Berger A C, Dengler R. Treatment of biceps-triceps co-contractions after nerve regeneration in obstretical brachial plexus lesions - a new indication for botulinum toxin type A.  Neurology. 2000;  55 112-114
    PubMedGoogle Scholar
  • 25 Dressler D. Botulinum-Toxin-Therapie. Stuttgart; Thieme 1995: 33
    Google Scholar
  • 26 Rosales R L, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.  Muscle Nerve. 1996;  19 488-496
    PubMedGoogle Scholar
  • 27 Filippi G M, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles.  Acta Otolaryngol. 1993;  113 400-404
    CrossrefPubMedGoogle Scholar
  • 28 Wiegand H, Erdmann G, Wellhöner H H. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection.  Naunyn Schmiederbergs Arch Pharmacol. 1976;  292 161-165
    CrossrefPubMedGoogle Scholar
  • 29 Wiegand H, Wellhöner H H. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex.  Naunyn Schmiederbergs Arch Pharmacol. 1977;  298 235-238
    PubMedGoogle Scholar
  • 30 Guyer B M. Mechanisms of botulinum toxin in the relief of chronic pain.  Curr Rev Pain. 1999;  3 427-431
    PubMedGoogle Scholar
  • 31 Göbel H, Heinze A, Heinze-Kuhn K, Austermann C. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes.  Pain. 2001;  91 195-199
    CrossrefPubMedGoogle Scholar
  • 32 Ishikawa H, Mitsui Y, Yoshitomi T, Mashimo K, Aoki S, Mukuno K, Shimizu K. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles.  Jpn J Ophthalmol. 2000;  44 106-109
    CrossrefPubMedGoogle Scholar
  • 33 Humm A M, Pabst C, Lauterburg T, Burgunder J M. Enkephalin and aFGF are differentially regulated in rat spinal motoneurons after chemodenervation with botulinum toxin.  Exp Neurol. 2000;  161 361-372
    CrossrefPubMedGoogle Scholar
  • 34 Atwood H A, MacKay W A. Neurophysiologie. Stuttgart, New York; Schattauer 1994
    Google Scholar
  • 35 Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis.  Pain. 1997;  69 279-286
    CrossrefPubMedGoogle Scholar
  • 36 Williams A. Consensus statement for the management of focal dystonias.  Br J Hosp Med. 1993;  50 655-659
    PubMedGoogle Scholar
  • 37 Rollnik J D, Matzke M, Wohlfarth K, Dengler R, Bigalke H. Low-dose albumin-diluted botulinum toxin therapy of cervical dystonia, blepharospasm, and facial hemispasm under EMG guidance - an open label study.  European Neurology. 2000;  43 9-12
    PubMedGoogle Scholar
  • 38 Poungvarin N. Writer's cramp: the experience with botulinum toxin injections in 25 patients.  J Med Assoc Thailand. 1991;  74 239-247
    PubMedGoogle Scholar
  • 39 Dunne J W, Heye N, Dunne S L. Treatment of chronic limb spasticity with botulinum toxin A.  J Neurol Neurosurg Psychiatry. 1995;  58 232-235
    PubMedGoogle Scholar
  • 40 Naumann M. Klinische Anwendungen von Botulinumtoxin. Bremen; UNI-MED 1998: 10-20
    Google Scholar
  • 41 Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain.  Current Opinion in Rheumatology. 1998;  10 95-103
    PubMedGoogle Scholar
  • 42 Borg-Stein J, Stein J. Trigger points and tender points: one and the same? Does injection treatment help?.  Rheumatic Diseases Clinics of North America. 1996;  22 305-322
    PubMedGoogle Scholar
  • 43 Raj P P. Botulinum toxin for the treatment of pain.  Pain Digest. 1998;  8 335-336
    PubMedGoogle Scholar
  • 44 Hong C Z, Simons D G. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points.  Archives of Physical Medicine and Rehabilitation. 1998;  79 863-872
    CrossrefPubMedGoogle Scholar
  • 45 Hubbard D R, Berkoff G M. Myofascial trigger points show spontaneous needle EMG activity.  Spine. 1993;  18 1803-1807
    CrossrefPubMedGoogle Scholar
  • 46 Porta M, Perretti A, Gamba M, Luccarelli G, Fornari M. The rationale and results of treating muscle spasm and myofascial syndromes with botulinum toxin type A.  Pain Digest. 1998;  8 346-352
    PubMedGoogle Scholar
  • 47 Lou L, Racz G B. Examination of trigger points that produce myofascial pain syndrome.  Pain Digest. 1998;  8 364-375
    PubMedGoogle Scholar
  • 48 Zwart J A, Bovim G, Sand T, Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles.  Headache. 1994;  34 458-462
    CrossrefPubMedGoogle Scholar
  • 49 Krack P, Hornig C, Dorndorf W. Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospam.  Mov Disord. 1995;  10 388
    PubMedGoogle Scholar
  • 50 Relja M A. Treatment of tension-type headache with botulinum toxin: 1-year follow-up.  Cephalalgia. 2000;  20 336
    PubMedGoogle Scholar
  • 51 Smuts J A, Barnard P WA. Botulinum toxin type A in the treatment of headache syndromes: a clinical report of 79 patients.  Cephalalgia. 2000;  20 332
    CrossrefPubMedGoogle Scholar
  • 52 Göbel H, Lindner V, Krack P, Heinze A, Gaartz N, Deuschl G. Treatment of chronic tension-type headache with botulinum toxin.  Cephalalgia. 1999;  19 455
    PubMedGoogle Scholar
  • 53 Rollnik J D, Karst M, Fink M, Dengler R. Botulinum A toxin and EMG - a key to the understanding of chronic tension-type headaches?. Headache 2001 (in press)
    Google Scholar
  • 54 Jensen R, Fuglsang-Frederiksen A, Olesen J. Quantitative EMG of pericranial muscles. Reproducibility and variability.  Electroencephalogr Clin Neurophysiol. 1993;  89 1-9
    PubMedGoogle Scholar
  • 55 Brin M F, Swope D M, O'Brian C, Abasi S, Pogoda J M. Botox for migraine: double-blind, placebo-controlled region-specific evaluation.  Cephalalgia. 2000;  20 421-422
    CrossrefPubMedGoogle Scholar
  • 56 Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as migraine preventive treatment. For the Botox Migraine Clinical Research Group.  Headache. 2000;  40 445-450
    CrossrefPubMedGoogle Scholar
  • 57 Binder W J, Brin M F, Blitzer A, Schoenrock L D, Pogoda J M. Botulinum toxin type A (Botox) for the treatment of migraine headaches: an open-label study.  Otolaryngol Head Neck Surg. 2000;  123 669-676
    CrossrefPubMedGoogle Scholar
  • 58 Mauskop A, Basdeo R. Botulinum toxin A is an effect prophylactic therapy of migraines.  Cephalalgia. 2000;  20 422
    PubMedGoogle Scholar
  • 59 Freund B, Schwartz M. The use of botulinum toxin A in the treatment of refractory cluster headache: case reports.  Cephalalgia. 2000;  20 329-330
    PubMedGoogle Scholar
  • 60 Ginies P R, Fraimout J L, Kong A, Siou D, Chevallier J, Mann C, Colson P. Treatment of cluster headache by subcutaneous injection of botulinum toxin. 8th World Congress of Pain, Poster Presentation 1996 50
    Google Scholar
  • 61 Freund B J, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study.  Headache. 2000;  40 231-236
    CrossrefPubMedGoogle Scholar
  • 62 Christiansen J, Bruun E, Skjoldbye B, Hagen K. Chronic idiopathic anal pain: analysis of ultrasonography, pathology, and treatment.  Dis Colon Rectum. 2001;  44 661-665
    PubMedGoogle Scholar

Priv.-Doz. Dr. med. Jens D. Rollnik

Neurologische Klinik mit Klinischer Neurophysiologie · Medizinische Hochschule Hannover

30623 Hannover

Email: rollnik.jens@mh-hannover.de

      >